Clinical Trial Update: Pilot Study Immunomonitoring Natural Killers Cells in Patients With Myeloid Malignancies Treated With Lenalidomide [NA]

View source ↗

Summary

A completed pilot clinical trial evaluated immunomonitoring of natural killer cells in patients with acute myeloid leukemia or myelodysplastic syndromes treated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

Sponsor: Institut Paoli-Calmettes | Conditions: Acute Myeloid Leukemia or Myelodysplasic Syndrome | NA | Status: COMPLETED